{"id":"autologous-blood-transfusion","safety":{"commonSideEffects":[{"rate":null,"effect":"Infection (if contamination occurs during collection/storage)"},{"rate":null,"effect":"Hemolysis"},{"rate":null,"effect":"Volume overload"}]},"_chembl":{"chemblId":"CHEMBL4594461","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This procedure involves collecting and storing a patient's own blood prior to surgery or treatment, then reinfusing it to replace blood loss and maintain hemoglobin levels. It eliminates the risk of transfusion-transmitted infections and immune reactions associated with allogeneic (donor) blood products. The approach is used to reduce dependence on banked blood supplies and improve patient safety.","oneSentence":"Autologous blood transfusion returns a patient's own previously collected blood to restore circulating volume and oxygen-carrying capacity.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:02:57.280Z","_scrapedBy":"cloudflare-swarm","_wikipedia":{"url":"https://en.wikipedia.org/wiki/Autotransplantation","title":"Autotransplantation","extract":"Autotransplantation, also called autologous transplantation, is the surgical transplantation of organs, tissues, or even particular proteins from one site in an individual’s body to another site within the same person."},"indications":{"approved":[{"name":"Blood loss management in surgical patients"},{"name":"Reduction of allogeneic transfusion requirements"}]},"trialDetails":[{"nctId":"NCT01306019","phase":"PHASE1, PHASE2","title":"Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2012-09-25","conditions":"X-linked Severe Combined Immunodeficiency (XSCID)","enrollment":40},{"nctId":"NCT05477563","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease","status":"RECRUITING","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2022-08-02","conditions":"Beta-Thalassemia, Thalassemia, Hematologic Diseases","enrollment":26},{"nctId":"NCT03889834","phase":"NA","title":"Biological Parameters Changes After Autologous Blood Transfusion of Red Blood Cells (200 ml) in Healthy Volunteers.","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-01-25","conditions":"The Focus is on the Detection of the Consequences of Autologous Blood Transfusion in Healthy Volunteers","enrollment":30},{"nctId":"NCT05889494","phase":"NA","title":"Autologous Whole Blood Management for Transfusion Reduction in Adult Cardiac Surgery Patients","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2025-03-24","conditions":"Postoperative Hemorrhage, Postoperative Anemia, Postoperative Blood Loss","enrollment":64},{"nctId":"NCT07476183","phase":"PHASE1","title":"Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia","status":"NOT_YET_RECRUITING","sponsor":"Apriligen, Inc.","startDate":"2026-03","conditions":"RPS19 Deficient Diamond-Blackfan Anemia","enrollment":4},{"nctId":"NCT05189925","phase":"PHASE1","title":"NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-07-22","conditions":"Chronic Granulomatous Disease, Infection","enrollment":25},{"nctId":"NCT07446647","phase":"PHASE1","title":"Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery and Survival After Autologous Transfusion","status":"NOT_YET_RECRUITING","sponsor":"Jose Cancelas","startDate":"2026-03","conditions":"Healthy Volunteer Red Blood Cell Labeling Study; Not Disease Focused","enrollment":20},{"nctId":"NCT05356195","phase":"PHASE3","title":"Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2022-05-03","conditions":"Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn","enrollment":16},{"nctId":"NCT07436767","phase":"NA","title":"Safety and Efficacy of KL003 Cell Injection in Severe Sickle Cell Disease","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-03-01","conditions":"Sickle Cell Disease","enrollment":3},{"nctId":"NCT07420582","phase":"","title":"Antegrade Autologous Blood Reinfusion After CPB","status":"RECRUITING","sponsor":"Kocaeli City Hospital","startDate":"2026-02-23","conditions":"Coronary Artery Disease","enrollment":130},{"nctId":"NCT06364774","phase":"PHASE1, PHASE2","title":"ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2025-04-14","conditions":"Beta-Thalassemia","enrollment":12},{"nctId":"NCT04390971","phase":"NA","title":"Safety and Efficacy Evaluation of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia","status":"COMPLETED","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2023-02-10","conditions":"Transfusion Dependent Beta-Thalassaemia","enrollment":3},{"nctId":"NCT06647979","phase":"PHASE1","title":"Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies","status":"RECRUITING","sponsor":"Daniel Bauer","startDate":"2025-12-01","conditions":"Sickle Cell Disease, Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0), Beta-Thalassemia","enrollment":10},{"nctId":"NCT07375563","phase":"PHASE3","title":"Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma","status":"RECRUITING","sponsor":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","startDate":"2025-11-19","conditions":"Neuroblastoma (NB), Ganglioneuroblastoma","enrollment":5},{"nctId":"NCT06629324","phase":"PHASE2","title":"Evaluating Bone Marrow Cell Transplant for Treating Cerebral Palsy From Brain Hypoxia","status":"RECRUITING","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2024-10-15","conditions":"Autism Spectrum Disorder","enrollment":58},{"nctId":"NCT05577312","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia","status":"ENROLLING_BY_INVITATION","sponsor":"Bioray Laboratories","startDate":"2022-11-01","conditions":"Beta-Thalassemia","enrollment":39},{"nctId":"NCT03655678","phase":"PHASE2, PHASE3","title":"A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia","status":"COMPLETED","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2018-09-14","conditions":"Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn","enrollment":59},{"nctId":"NCT03999229","phase":"PHASE1","title":"S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion","status":"RECRUITING","sponsor":"James Reynolds","startDate":"2019-07-25","conditions":"Transfusion Related Complication","enrollment":35},{"nctId":"NCT02570542","phase":"PHASE2","title":"Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2015-10","conditions":"Diffuse Large B-cell Lymphoma (DLBCL), Relapsed Diffuse Large B-cell Lymphoma (DLBCL), Refractory Diffuse Large B-cell Lymphoma (DLBCL)","enrollment":59},{"nctId":"NCT06308159","phase":"PHASE1, PHASE2","title":"An Open-label Study of a Gene Therapy Product (Vebeglogene Autotemcel) in Transfusion Dependent Beta-Thalassemia","status":"RECRUITING","sponsor":"Lantu Biopharma","startDate":"2024-05-11","conditions":"Beta-Thalassemia","enrollment":6},{"nctId":"NCT06824753","phase":"NA","title":"Postoperative Use Of Pump Blood İn Cardiopulmonary Bypass Surgery","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2023-04-01","conditions":"Cardio-pulmonary Bypass","enrollment":60},{"nctId":"NCT05145062","phase":"","title":"Long - Term Follow Up of Sickle Cell Disease and Beta-thalassemia Subjects Previously Exposed to BIVV003 or ST-400.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sangamo Therapeutics","startDate":"2021-12-21","conditions":"Blood and Lymphatic Diseases","enrollment":8},{"nctId":"NCT07207668","phase":"NA","title":"i-PRF & Root Surface Biomodification","status":"COMPLETED","sponsor":"Halil Ata BIÇAKÇIOGLU","startDate":"2023-02-01","conditions":"Chronic Periodontitis (Disorder), Periodontitis","enrollment":42},{"nctId":"NCT05835882","phase":"NA","title":"Blood Salvage From Liver Donors: a Feasibility Pilot Study","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2023-06-01","conditions":"Liver Transplantation, Erythrocyte Transfusion","enrollment":10},{"nctId":"NCT07064954","phase":"PHASE2, PHASE3","title":"Autologous Cold-stored Apheresis Platelets","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-09-01","conditions":"Bleeding, Platelets, Cardiopulmonary Bypass","enrollment":100},{"nctId":"NCT05146726","phase":"","title":"Patient Blood Management Charité (PBM-Charité): Structured Detection, Differentiated Diagnostics and Therapy of Preoperative Anemia and Use of Machine Autotransfusion in Elective Interventions","status":"RECRUITING","sponsor":"Charite University, Berlin, Germany","startDate":"2022-02-02","conditions":"Anemia","enrollment":2700},{"nctId":"NCT06425614","phase":"NA","title":"COmbined pLaTelet and eRythrocyte AutotransfusioN During Cardiac surgEry (COLTRANE) Trial","status":"RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2024-07-15","conditions":"On-pump Cardiac Surgery, High Risk for Bleeding, Autotransfusion","enrollment":570},{"nctId":"NCT07021534","phase":"PHASE1","title":"Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial","status":"RECRUITING","sponsor":"Zhejiang University","startDate":"2025-06-10","conditions":"Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments","enrollment":12},{"nctId":"NCT07005661","phase":"PHASE2, PHASE3","title":"Use of PRP in Open Surgery for Type A Aortic Dissection","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-06-30","conditions":"Aortic Dissection Type A, Transfusions, Platelet Rich Plasma (PRP)","enrollment":250},{"nctId":"NCT02633943","phase":"","title":"Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Genetix Biotherapeutics Inc.","startDate":"2014-01","conditions":"Transfusion-dependent Beta-Thalassemia","enrollment":66},{"nctId":"NCT06629311","phase":"","title":"Platelet and Autotransfusion Device in Cardiac Surgery","status":"RECRUITING","sponsor":"University Hospital, Strasbourg, France","startDate":"2025-02-04","conditions":"Platelets, Autotransfusion Device","enrollment":100},{"nctId":"NCT05444894","phase":"PHASE1, PHASE2","title":"EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Editas Medicine, Inc.","startDate":"2022-04-29","conditions":"Transfusion Dependent Beta Thalassemia, Hemoglobinopathies, Thalassemia Major","enrollment":9},{"nctId":"NCT06363760","phase":"","title":"A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301","status":"ENROLLING_BY_INVITATION","sponsor":"Editas Medicine, Inc.","startDate":"2024-06-17","conditions":"Sickle Cell Disease, Transfusion-dependent Beta-Thalassemia, Hemoglobinopathies","enrollment":54},{"nctId":"NCT05752123","phase":"NA","title":"A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia.","status":"TERMINATED","sponsor":"EdiGene (GuangZhou) Inc.","startDate":"2023-02-18","conditions":"Transfusion Dependent Beta-Thalassaemia","enrollment":2},{"nctId":"NCT06153160","phase":"NA","title":"\"The Effect of the Use of an Autotransfusion Device on Hemodynamic Parameters During Resuscitation\".","status":"COMPLETED","sponsor":"University Medical Centre Maribor","startDate":"2023-11-22","conditions":"Out of Hospital Cardiac Arrest, Cardiac Arrest","enrollment":24},{"nctId":"NCT04925206","phase":"PHASE1","title":"A Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-Thalassaemia","status":"TERMINATED","sponsor":"EdiGene (GuangZhou) Inc.","startDate":"2021-08-17","conditions":"Transfusion Dependent Beta-Thalassaemia","enrollment":8},{"nctId":"NCT05647057","phase":"NA","title":"CPB Prime Fluid Strategies to Preserve Mcirocirculatory Perfusion","status":"COMPLETED","sponsor":"Amsterdam UMC, location VUmc","startDate":"2023-07-10","conditions":"Endothelial Dysfunction, Hemolysis, Fluid Overload","enrollment":48},{"nctId":"NCT05612477","phase":"NA","title":"Blood Salvage in Orthotopic Liver Transplantation With HCC","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2023-01-21","conditions":"Hepatocellular Carcinoma, Surgery","enrollment":30},{"nctId":"NCT02338947","phase":"NA","title":"Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2019-01-01","conditions":"Frail Elderly, Coronary Artery Disease","enrollment":440},{"nctId":"NCT06230198","phase":"NA","title":"The Effect of Retrograde Autologous Priming on Transfusion Requirements After Cardiac Surgery","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2024-12-04","conditions":"Red Blood Cell Transfusion","enrollment":4500},{"nctId":"NCT04924491","phase":"PHASE1, PHASE2","title":"Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Prevent Rejection in Heart Transplant Children","status":"RECRUITING","sponsor":"Rafael Correa-Rocha","startDate":"2020-09-10","conditions":"Heart Transplantation","enrollment":11},{"nctId":"NCT06788080","phase":"EARLY_PHASE1","title":"Optimization of Biotinylation Protocol for Studies of Red Blood Cell Survival and Function After Transfusion","status":"COMPLETED","sponsor":"Vitalant Research Institute","startDate":"2024-03-07","conditions":"Measuring Red Blood Cell Survival After Transfusion","enrollment":12},{"nctId":"NCT05665140","phase":"PHASE2, PHASE3","title":"Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Patients","status":"RECRUITING","sponsor":"University Hopsital Schleswig Holstein Campus Lübeck","startDate":"2023-02-03","conditions":"Newly Diagnosed Multiple Myeloma","enrollment":100},{"nctId":"NCT06399536","phase":"NA","title":"Individualized ANH for Non-cardiac Surgery","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2024-06-01","conditions":"Transfusion Related Complication, Hemodilution","enrollment":40},{"nctId":"NCT05745532","phase":"EARLY_PHASE1","title":"Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients","status":"RECRUITING","sponsor":"Shenzhen Hemogen","startDate":"2020-12-01","conditions":"β-thalassemia","enrollment":10},{"nctId":"NCT05864170","phase":"EARLY_PHASE1","title":"the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia","status":"RECRUITING","sponsor":"Shenzhen Hemogen","startDate":"2022-05-27","conditions":"β-thalassemia","enrollment":3},{"nctId":"NCT05851105","phase":"EARLY_PHASE1","title":"the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With Transfusion-Dependent α-Thalassemia","status":"RECRUITING","sponsor":"Shenzhen Hemogen","startDate":"2022-10-08","conditions":"α-thalassemia","enrollment":3},{"nctId":"NCT03204357","phase":"NA","title":"Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2022-01-24","conditions":"Cardiac Disease, Bleeding Postoperative","enrollment":70},{"nctId":"NCT04840875","phase":"PHASE1","title":"Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphoma","status":"COMPLETED","sponsor":"Beijing Boren Hospital","startDate":"2021-09-14","conditions":"T Cell Lymphoma, T-cell Leukemia","enrollment":16},{"nctId":"NCT06655662","phase":"PHASE1","title":"Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients.","status":"RECRUITING","sponsor":"Shenzhen Hemogen","startDate":"2024-06-12","conditions":"Β-thalassemia","enrollment":8},{"nctId":"NCT01639690","phase":"PHASE1","title":"ß-Thalassemia Major with Autologous CD34+ Hematopoietic Progenitor Cells Transduced with TNS9.3.55 a Lentiviral Vector Encoding the Normal Human ß-Globin Gene","status":"ACTIVE_NOT_RECRUITING","sponsor":"San Rocco Therapeutics","startDate":"2012-07","conditions":"Confirmed Diagnosis of ß-thalassemia Major","enrollment":10},{"nctId":"NCT06609993","phase":"NA","title":"AoA Guided Thoracic Epidural Analgesia for Abdominal Aortic Repair","status":"COMPLETED","sponsor":"Michał Stasiowski","startDate":"2017-12-12","conditions":"Aortic Aneurysm, Postoperative Nausea and Vomiting, Postoperative Pain","enrollment":75},{"nctId":"NCT06244264","phase":"NA","title":"The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis","status":"RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2024-03-15","conditions":"Spinal Metastases, Blood Transfusion Complication, Lung Cancer","enrollment":118},{"nctId":"NCT06465550","phase":"PHASE1","title":"A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Treating β-thalassemia Major","status":"RECRUITING","sponsor":"Shanghai BDgene Co., Ltd.","startDate":"2024-01-05","conditions":"β-thalassemia","enrollment":9},{"nctId":"NCT05776173","phase":"NA","title":"Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent β-thalassemia","status":"RECRUITING","sponsor":"Shanghai BDgene Co., Ltd.","startDate":"2023-08-10","conditions":"β-thalassemia Major","enrollment":10},{"nctId":"NCT05773729","phase":"NA","title":"Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Beta-thalassemia","status":"RECRUITING","sponsor":"Shanghai BDgene Co., Ltd.","startDate":"2023-09-15","conditions":"β-thalassemia","enrollment":10},{"nctId":"NCT06431100","phase":"","title":"a Single-arm, Single-center, Open Clinical Study","status":"RECRUITING","sponsor":"Beijing Geekgene Technology Co., LTD","startDate":"2023-07-19","conditions":"Gastric Cancer, Esophageal Cancer, Cervical Cancer","enrollment":10},{"nctId":"NCT03292263","phase":"PHASE1, PHASE2","title":"ASCT With Nivolumab in Patients With Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Petersburg State Pavlov Medical University","startDate":"2017-04-24","conditions":"Multiple Myeloma","enrollment":30},{"nctId":"NCT06357455","phase":"NA","title":"Platelet Count and Function After Usage of Two Different Cell Saver Devices During Liver Transplant Surgery","status":"NOT_YET_RECRUITING","sponsor":"Eduardo Schiffer","startDate":"2024-06-01","conditions":"Liver Transplant, Hemorrhage, Surgical","enrollment":40},{"nctId":"NCT06355739","phase":"NA","title":"CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+","status":"RECRUITING","sponsor":"Zhu Xiaofan","startDate":"2024-02-01","conditions":"B Lymphocytic Leukemia, B Lymphoblastic Lymphoma","enrollment":60},{"nctId":"NCT03958097","phase":"PHASE2","title":"Natural Killer(NK) Cell Combined With Programmed Death-1(PD-1) Antibody as Second Line Therapy for Advanced Driver Mutation Negative Non-small Cell Lung Cancer","status":"COMPLETED","sponsor":"The First Hospital of Jilin University","startDate":"2019-05-17","conditions":"Non-small Cell Lung Cancer","enrollment":20},{"nctId":"NCT00596154","phase":"PHASE2","title":"Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2004-12","conditions":"CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma","enrollment":33},{"nctId":"NCT06307158","phase":"","title":"Influence of Intraoperative Blood Salvage and Autotransfusion on Tumor Recurrence After Deceased Donor Liver Transplantation","status":"COMPLETED","sponsor":"Zhejiang University","startDate":"2015-01-01","conditions":"Liver Transplant; Complications","enrollment":998},{"nctId":"NCT03207009","phase":"PHASE3","title":"A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia","status":"COMPLETED","sponsor":"Genetix Biotherapeutics Inc.","startDate":"2017-06-08","conditions":"Beta-Thalassemia","enrollment":19},{"nctId":"NCT05452538","phase":"","title":"AutoTransfusion Versus TRAnsfusion in Cancer Surgery","status":"COMPLETED","sponsor":"Centre Leon Berard","startDate":"2021-01-01","conditions":"Hemorrhage, Cancer Surgery, Transfusion","enrollment":5808},{"nctId":"NCT04478123","phase":"PHASE2","title":"Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2020-07-14","conditions":"Multiple Myeloma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma","enrollment":62},{"nctId":"NCT06236178","phase":"NA","title":"Comparing Autologous Blood, Corticosteroid, and Their Combined Injection for Treating Lateral Epicondylitis","status":"COMPLETED","sponsor":"Istanbul Training and Research Hospital","startDate":"2023-01-01","conditions":"Lateral Epicondylitis, Comparing Autologous Blood Corticosteroid and Their Combined Injection for Treating Lateral Epicondylitis","enrollment":119},{"nctId":"NCT03432364","phase":"PHASE1, PHASE2","title":"A Study to Assess the Safety, Tolerability, and Efficacy of ST-400 for Treatment of Transfusion-Dependent Beta-thalassemia (TDT)","status":"COMPLETED","sponsor":"Sangamo Therapeutics","startDate":"2018-03-29","conditions":"Transfusion Dependent Beta-thalassemia","enrollment":5},{"nctId":"NCT04514978","phase":"NA","title":"The Effect of Blood Donation on Hematological and Iron Indices and Detection of Autologous Blood Transfusion","status":"UNKNOWN","sponsor":"University of Copenhagen","startDate":"2018-10-01","conditions":"Healthy","enrollment":48},{"nctId":"NCT06149390","phase":"","title":"ASCT Versus Chemotherapy as First-Line Consolidation Therapy inT-Cell Lymphoma","status":"COMPLETED","sponsor":"Huazhong University of Science and Technology","startDate":"2014-01-01","conditions":"T-cell Lymphoma Adults","enrollment":347},{"nctId":"NCT06103214","phase":"NA","title":"The Effects of Hemodilution Methods in Patients Undergoing Primary Debulking Gynaecological Surgery","status":"COMPLETED","sponsor":"Zhejiang Cancer Hospital","startDate":"2017-01-01","conditions":"Ovarian Neoplasm Epithelial","enrollment":144},{"nctId":"NCT06041620","phase":"NA","title":"Safety and Efficacy Evaluation of Autologous CRISPR-Cas12b Edited Hematopoietic Stem Cells","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2023-08-31","conditions":"Thalassemia, Beta, Thalassemia Major","enrollment":2},{"nctId":"NCT05991336","phase":"","title":"Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2023-06-05","conditions":"Transfusion-dependent Beta-Thalassemia, Gene Therapy","enrollment":100},{"nctId":"NCT02906202","phase":"PHASE3","title":"A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype","status":"COMPLETED","sponsor":"Genetix Biotherapeutics Inc.","startDate":"2016-08-08","conditions":"Beta-Thalassemia","enrollment":24},{"nctId":"NCT01264315","phase":"PHASE2","title":"Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant","status":"COMPLETED","sponsor":"Fondazione EMN Italy Onlus","startDate":"2008-09","conditions":"Multiple Myeloma","enrollment":53},{"nctId":"NCT05762510","phase":"EARLY_PHASE1","title":"A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]","status":"RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2023-02-22","conditions":"Transfusion Dependent Beta-Thalassemia","enrollment":5},{"nctId":"NCT05401175","phase":"NA","title":"Hematopoietic Stem Cell-containing Autologous Blood Transfusion for Bone Marrow Protection in Patients With Cervical Cancer","status":"RECRUITING","sponsor":"Chongqing University Cancer Hospital","startDate":"2022-04-13","conditions":"Cervical Cancer","enrollment":40},{"nctId":"NCT04927988","phase":"NA","title":"Blood Components Changes by Using of Ringer's Lactated as Detergent In Autologous Blood Cell Transfusion","status":"WITHDRAWN","sponsor":"Maternal and Child Health Hospital of Foshan","startDate":"2021-10","conditions":"Placenta Accreta Spectrum","enrollment":""},{"nctId":"NCT05757245","phase":"PHASE1","title":"A Study Evaluating the Safety and Efficacy of the GMCN-508A Drug Product in Transfusion-dependent α-Thalassemia Participants","status":"RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2023-05-08","conditions":"Transfusion-dependent α-Thalassemia","enrollment":5},{"nctId":"NCT05761457","phase":"NA","title":"Efficacy and Safety of Autologous Cryopreserved Platelets in Patients With PTR","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2023-03-01","conditions":"Platelet Transfusion Refractoriness","enrollment":25},{"nctId":"NCT02654028","phase":"NA","title":"Association Between Autologous Transfusion and Recurrence-free Survival in Patients With HCC After Resection","status":"COMPLETED","sponsor":"Guangxi Medical University","startDate":"2019-01-05","conditions":"Liver Cancer","enrollment":618},{"nctId":"NCT01072370","phase":"PHASE1, PHASE2","title":"Safety and Effectiveness of Cord Blood Stem Cell Infusion for the Treatment of Cerebral Palsy in Children","status":"WITHDRAWN","sponsor":"Augusta University","startDate":"2010-01","conditions":"Cerebral Palsy","enrollment":""},{"nctId":"NCT01730118","phase":"PHASE1","title":"Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2013-03-04","conditions":"Breast Neoplasms, Breast Cancer, Adenocarcinomas","enrollment":33},{"nctId":"NCT01773395","phase":"PHASE2","title":"GVAX vs. Placebo for MDS/AML After Allo HSCT","status":"TERMINATED","sponsor":"Dana-Farber Cancer Institute","startDate":"2013-01-08","conditions":"Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia","enrollment":123},{"nctId":"NCT05461235","phase":"PHASE2","title":"Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma","status":"UNKNOWN","sponsor":"China Medical University, China","startDate":"2022-07-15","conditions":"PD-1 Antibody, DC-Cell, NK-Cell","enrollment":1},{"nctId":"NCT05425654","phase":"PHASE2","title":"RL-MPV Followed by BBC HCT Using Autologous Stem Cells and Maintenance Therapy With Nivolumab for Newly Diagnosed PCNSL","status":"RECRUITING","sponsor":"National Research Center for Hematology, Russia","startDate":"2021-05-17","conditions":"Primary CNS Lymphoma","enrollment":30},{"nctId":"NCT05401162","phase":"NA","title":"Chemotherapy Supported by Autologous Hematopoietic Stem Cells","status":"RECRUITING","sponsor":"Chongqing University Cancer Hospital","startDate":"2022-04-15","conditions":"Ovarian Cancer","enrollment":40},{"nctId":"NCT03385486","phase":"PHASE1","title":"Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors","status":"UNKNOWN","sponsor":"Taiga Biotechnologies, Inc.","startDate":"2019-06-02","conditions":"Stage III Melanoma, Stage IV Melanoma","enrollment":72},{"nctId":"NCT02151526","phase":"PHASE1, PHASE2","title":"A Study Evaluating the Safety and Efficacy of LentiGlobin BB305 Drug Product in β-Thalassemia Major (Also Referred to as Transfusion-dependent β-Thalassemia [TDT]) and Sickle Cell Disease","status":"COMPLETED","sponsor":"Genetix Biotherapeutics Inc.","startDate":"2013-06-07","conditions":"Beta-Thalassemia Major, Sickle Cell Disease","enrollment":7},{"nctId":"NCT00305344","phase":"PHASE1, PHASE2","title":"Umbilical Cord Blood Infusion to Treat Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Florida","startDate":"2005-04","conditions":"Type 1 Diabetes Mellitus","enrollment":23},{"nctId":"NCT04640246","phase":"PHASE1, PHASE2","title":"Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies","status":"UNKNOWN","sponsor":"Taiga Biotechnologies, Inc.","startDate":"2021-01-25","conditions":"Cancer, Tumor, Solid, Refractory Cancer","enrollment":60},{"nctId":"NCT04588350","phase":"NA","title":"Clinical Investigation Evaluating a New Autotransfusion Device in Cardiac Surgery","status":"COMPLETED","sponsor":"i-SEP","startDate":"2020-09-28","conditions":"Hemorrhage, Blood Loss, Surgical Blood Loss","enrollment":50},{"nctId":"NCT01251042","phase":"NA","title":"Comparison Between Return and Wastage of Your Own Blood, Collected During Spinal Surgery, for Verification of Safety When Returning Blood","status":"COMPLETED","sponsor":"Wellspect HealthCare","startDate":"2010-10","conditions":"Spinal Surgery","enrollment":51},{"nctId":"NCT00839241","phase":"NA","title":"A Clinical Study to Investigate if Transfusion of Patients Own Shed Blood Improves the Immunological Status in Comparison to Transfusion of Donor Blood (\"Bank Blood\")","status":"COMPLETED","sponsor":"Wellspect HealthCare","startDate":"2009-01","conditions":"Arthroplasty, Replacement, Knee, Blood Transfusion, Autologous, Blood Transfusion","enrollment":45},{"nctId":"NCT05111028","phase":"PHASE1, PHASE2","title":"Reversal of Aspirin Antiplatelet Therapy With Cold Stored Platelets","status":"UNKNOWN","sponsor":"Bloodworks","startDate":"2020-11-20","conditions":"Reversal of Platelet Aggregation Inhibitors","enrollment":10},{"nctId":"NCT04846439","phase":"PHASE1, PHASE2","title":"Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2021-04-29","conditions":"Platelet Transfusion Refractoriness, Acute Leukemia in Remission","enrollment":20},{"nctId":"NCT00731588","phase":"PHASE2","title":"Red Blood Cell (RBC) Survival Following Transfusion in Infants","status":"COMPLETED","sponsor":"John A Widness","startDate":"2008-06","conditions":"Neonatal Anemia","enrollment":140},{"nctId":"NCT02075970","phase":"PHASE2","title":"Optimized Erythropoietin (EPO) Treatment","status":"COMPLETED","sponsor":"John A Widness","startDate":"2014-06","conditions":"Neonatal Anemia","enrollment":62},{"nctId":"NCT04768816","phase":"PHASE1","title":"Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Autism Spectrum Disorder","status":"UNKNOWN","sponsor":"Guangdong Women and Children Hospital","startDate":"2019-07-01","conditions":"Safety Issues;Effect of Drugs","enrollment":25},{"nctId":"NCT04243382","phase":"PHASE2","title":"Treatment of Children With Autistic Spectrum Disorder With Autologous Umbilical Cord Blood, a Pilot Study","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2020-02-27","conditions":"Autistic Spectrum Disorder","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Autologous blood transfusion","genericName":"Autologous blood transfusion","companyName":"Centre Hospitalier Universitaire Vaudois","companyId":"centre-hospitalier-universitaire-vaudois","modality":"Biologic","firstApprovalDate":"","aiSummary":"Autologous blood transfusion returns a patient's own previously collected blood to restore circulating volume and oxygen-carrying capacity. Used for Blood loss management in surgical patients, Reduction of allogeneic transfusion requirements.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}